The first use of POLARx cryoballoon catheter for pulmonary vein isolation in patients with atrial fibrillation: case series
https://doi.org/10.35336/VA-2022-4-07
Abstract
There is the first clinical use of POLARx cryoballoon catheter for pulmonary vein isolation in patients with atrial fibrillation in Russian Federation.
About the Authors
E. A. Artyukhina
Vishnevskiy National Medical Research Center of Surgery
Russian Federation
Russian Federation
Moscow, 27 Bolshaya Serpukhovskaya str.
N. M. Kuznetsov
Vishnevskiy National Medical Research Center of Surgery
Russian Federation
Russian Federation
Kuznetsov Nikita
Moscow, 27 Bolshaya Serpukhovskaya str.
I. A. Taymasova
Vishnevskiy National Medical Research Center of Surgery
Russian Federation
Russian Federation
Moscow, 27 Bolshaya Serpukhovskaya str.
A. Sh. Revishvili
Vishnevskiy National Medical Research Center of Surgery
Russian Federation
Russian Federation
Moscow, 27 Bolshaya Serpukhovskaya str.
References
1. Steinberg BA, Holmes DN, Pieper K, et al. Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AF. Circ Arrhythm Electrophysiol. 2020;13(5): e007775. https://doi.org/10.1161/CIRCEP.119.007775.
2. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC [published correction appears in Eur Heart J. 2021 Feb 1;42(5):507] [published correction appears in Eur Heart J. 2021 Feb 1;42(5):546- 547] [published correction appears in Eur Heart J. 2021 Oct 21;42(40):4194]. Eur Heart J. 2021;42(5): 373-498. https://doi.org/10.1093/eurheartj/ehaa612.
3. Boveda S, Metzner A, Nguyen DQ, et al. Single-Procedure Outcomes and Quality-of-Life Improvement 12 Months Post-Cryoballoon Ablation in Persistent Atrial Fibrillation: Results From the Multicenter CRYO4PERSISTENT AF Trial. JACC Clin Electrophysiol. 2018;4(11): 1440-1447. https://doi.org/10.1016/j.jacep.2018.07.007.
4. Su WW, Reddy VY, Bhasin K, et al. Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial. Heart Rhythm. 2020;17(11): 1841-1847. https://doi.org/10.1016/j.hrthm.2020.06.020.
5. Fortuni F, Casula M, Sanzo A, et al. Meta-Analysis Comparing Cryoballoon Versus Radiofrequency as First Ablation Procedure for Atrial Fibrillation. Am J Cardiol. 2020;125(8): 1170-1179. https://doi.org/10.1016/j.amjcard.2020.01.016.
6. Murray MI, Arnold A, Younis M, Varghese S, Zeiher AM. Cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials. Clin Res Cardiol. 2018;107(8): 658-669. https://doi.org/10.1007/s00392-018-1232-4.
7. Kuck KH, Brugada J, Fürnkranz A, et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2016;374(23): 2235-2245. https://doi.org/10.1056/NEJMoa1602014.
8. Kuck KH, Fürnkranz A, Chun KR, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37(38): 2858-2865. https://doi.org/10.1093/eurheartj/ehw285.
9. Kuck KH, Albenque JP, Chun KJ, et al. Repeat Ablationfor Atrial Fibrillation Recurrence Post Cryoballoon or Radiofrequency Ablation in the FIRE AND ICE Trial. Circ Arrhythm Electrophysiol. 2019;12(6): e007247. https://doi.org/10.1161/CIRCEP.119.007247.
10. Reissmann B, Metzner A, Kuck KH. Cryoballoon ablation versus radiofrequency ablation for atrial fibrillation. Trends Cardiovasc Med. 2017;27(4): 271-277. https://doi.org/10.1016/j.tcm.2016.12.002.
11. Assaf A, Bhagwandien R, Szili-Torok T, Yap SC. Comparison of procedural efficacy, balloon nadir temperature, and incidence of phrenic nerve palsy between two cryoballoon technologies for pulmonary vein isolation: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2021;32(9): 2424-2431. https://doi.org/10.1111/jce.15182.
12. Creta A, Kanthasamy V, Schilling RJ, et al. First experience of POLARx™ versus Arctic Front Advance™: An early technology comparison. J Cardiovasc Electrophysiol. 2021;32(4): 925-930. https://doi.org/10.1111/jce.14951.
13. Kochi AN, Moltrasio M, Tundo F, et al. Cryoballoon atrial fibrillation ablation: Single-center safety and efficacy data using a novel cryoballoon technology compared to a historical balloon platform. J Cardiovasc Electrophysiol. 2021;32(3): 588-594. https://doi.org/10.1111/jce.14930.
14. Tilz RR, Meyer-Saraei R, Eitel C, et al. Novel Cryoballoon Ablation System for Single Shot Pulmonary Vein Isolation - The Prospective ICE-AGE-X Study. Circ J. 2021;85(8): 1296-1304. https://doi.org/10.1253/circj.CJ-21-0094.
15. Yap SC, Anic A, Breskovic T, et al. Comparison of procedural efficacy and biophysical parameters between two competing cryoballoon technologies for pulmonary vein isolation: Insights from an initial multicenter experience. J Cardiovasc Electrophysiol. 2021;32(3): 580-587. https://doi.org/10.1111/jce.14915.
Review
For citations:
Artyukhina E.A., Kuznetsov N.M., Taymasova I.A., Revishvili A.Sh. The first use of POLARx cryoballoon catheter for pulmonary vein isolation in patients with atrial fibrillation: case series. Journal of Arrhythmology. 2022;29(4):47-52. https://doi.org/10.35336/VA-2022-4-07
Views:
321
Email this article 